Risk factor
Poor trading liquidity
Profitability factor
Strong margins and returns
About
Indegene Limited operates as a global commercialization partner within the life sciences sector. The company assists biopharmaceutical, nascent biotechnology, and medical device organizations throughout their product's journey, from initial development and market introduction to sustained growth and impact. Its comprehensive offerings include a range of enterprise solutions for commercial, medical, and clinical operations, advanced omnichannel activation strategies, and its proprietary NEXT technology platforms. Established in 1998, the company maintains its headquarters in Bengaluru, India.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E
Target Price
The average target price of INDGN.BO is 570 and suggests 0.0456% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen